Systemic anticoagulation is associated with decreased mortality and morbidity in acute pancreatitis.

[1]  B. Baysal,et al.  Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled,open-label study. , 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[2]  Ying Wang,et al.  Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H. , 2019, The Journal of clinical investigation.

[3]  C. Thongprayoon,et al.  Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013–2014 , 2019, Lung.

[4]  P. Hart,et al.  The Changing Epidemiology of Acute Pancreatitis Hospitalizations: A Decade of Trends and the Impact of Chronic Pancreatitis , 2017, Pancreas.

[5]  Jennifer L. Lund,et al.  Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. , 2015, Gastroenterology.

[6]  R. Carnahan,et al.  A systematic review of validated methods for identifying pancreatitis using administrative data , 2012, Pharmacoepidemiology and drug safety.

[7]  T. Uchida,et al.  Antithrombin III Prevents Cerulein-Induced Acute Pancreatitis in Rats , 2009, Pancreas.

[8]  D. Radenkovic,et al.  d-Dimer in Acute Pancreatitis: A New Approach for an Early Assessment of Organ Failure , 2009, Pancreas.

[9]  Zhang Kai-cheng,et al.  Low Molecular Weight Heparin in the Treatment of Severe Acute Pancreatitis: A Multiple Centre Prospective Clinical Study , 2009 .

[10]  S. Konturek,et al.  Protective and therapeutic effect of heparin in acute pancreatitis. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[11]  C. Camargo,et al.  Increasing United States hospital admissions for acute pancreatitis, 1988-2003. , 2007, Annals of epidemiology.

[12]  D. Yadav,et al.  Trends in the Epidemiology of the First Attack of Acute Pancreatitis: A Systematic Review , 2006, Pancreas.

[13]  Masahiko Hirota,et al.  The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis , 2006, Journal of Gastroenterology.

[14]  Y. Takeyama,et al.  Elevation of plasma tissue factor levels in patients with severe acute pancreatitis , 2006, Journal of Gastroenterology.

[15]  M. Ohmuraya,et al.  Applicability of Disseminated Intravascular Coagulation Parameters in the Assessment of the Severity of Acute Pancreatitis , 2006, Pancreas.

[16]  C. Hack,et al.  Protective effect of antithrombin III in acute experimental pancreatitis in rats , 1992, Digestive Diseases and Sciences.

[17]  D. Radenkovic,et al.  Disorders of Hemostasis During the Surgical Management of Severe Necrotizing Pancreatitis , 2004, Pancreas.

[18]  L. Gullo,et al.  Coagulative Disorders in Human Acute Pancreatitis: Role for the D-Dimer , 2003, Pancreas.

[19]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[20]  J. Schölmerich,et al.  lnterleukin‐8 and neutrophil activation in acute pancreatitis , 1992, European journal of clinical investigation.

[21]  M. Büchler,et al.  Ultrastructure of human acute pancreatitis , 1986, International journal of pancreatology : official journal of the International Association of Pancreatology.

[22]  K. Ohlsson,et al.  Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. , 1986, Thrombosis research.

[23]  A. Aasen,et al.  Studies on pathological plasma proteolysis in patients with acute pancreatitis. A preliminary report. , 1982, Acta chirurgica Scandinavica. Supplementum.